Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytomegalovirus Infections | 10 | 2021 | 68 | 2.580 |
Why?
|
| Cytomegalovirus | 10 | 2020 | 94 | 1.640 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2020 | 679 | 1.170 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2021 | 9 | 0.690 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2020 | 186 | 0.680 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 72 | 0.620 |
Why?
|
| Immediate-Early Proteins | 2 | 2007 | 46 | 0.450 |
Why?
|
| Viral Matrix Proteins | 2 | 2007 | 50 | 0.450 |
Why?
|
| Infant | 8 | 2021 | 1719 | 0.430 |
Why?
|
| Phosphoproteins | 2 | 2007 | 224 | 0.420 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2015 | 642 | 0.420 |
Why?
|
| Viral Proteins | 2 | 2007 | 273 | 0.400 |
Why?
|
| Infant, Newborn | 6 | 2020 | 1439 | 0.290 |
Why?
|
| Evolution, Molecular | 3 | 2024 | 351 | 0.280 |
Why?
|
| Genetic Variation | 3 | 2015 | 395 | 0.260 |
Why?
|
| Biological Specimen Banks | 1 | 2024 | 23 | 0.210 |
Why?
|
| Specimen Handling | 1 | 2024 | 61 | 0.210 |
Why?
|
| Genetic Drift | 1 | 2024 | 15 | 0.210 |
Why?
|
| Herpesvirus 6, Human | 2 | 2014 | 18 | 0.190 |
Why?
|
| Humans | 24 | 2024 | 65837 | 0.190 |
Why?
|
| Monitoring, Immunologic | 1 | 2021 | 3 | 0.170 |
Why?
|
| Viral Load | 4 | 2022 | 230 | 0.170 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 51 | 0.170 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 55 | 0.170 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 170 | 0.160 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 80 | 0.160 |
Why?
|
| Immune Evasion | 1 | 2020 | 71 | 0.150 |
Why?
|
| Sensitivity and Specificity | 4 | 2023 | 1172 | 0.150 |
Why?
|
| Immunocompromised Host | 2 | 2017 | 104 | 0.150 |
Why?
|
| Peptides | 2 | 2020 | 593 | 0.140 |
Why?
|
| Liver Transplantation | 1 | 2020 | 222 | 0.130 |
Why?
|
| Antigens, Viral | 4 | 2021 | 130 | 0.130 |
Why?
|
| Mycobacterium haemophilum | 1 | 2017 | 4 | 0.130 |
Why?
|
| Mycobacterium Infections | 1 | 2017 | 15 | 0.130 |
Why?
|
| Opportunistic Infections | 1 | 2017 | 29 | 0.130 |
Why?
|
| Roseolovirus Infections | 2 | 2014 | 11 | 0.130 |
Why?
|
| Mothers | 1 | 2020 | 281 | 0.130 |
Why?
|
| DNA, Viral | 2 | 2015 | 232 | 0.120 |
Why?
|
| Genome, Viral | 2 | 2015 | 145 | 0.120 |
Why?
|
| DNA | 1 | 2021 | 853 | 0.120 |
Why?
|
| Crohn Disease | 1 | 2017 | 108 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2023 | 3339 | 0.110 |
Why?
|
| Information Seeking Behavior | 1 | 2014 | 39 | 0.100 |
Why?
|
| Cytomegalovirus Vaccines | 1 | 2013 | 5 | 0.100 |
Why?
|
| Pregnancy | 1 | 2020 | 2401 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2013 | 90 | 0.100 |
Why?
|
| Vaccines, DNA | 1 | 2013 | 98 | 0.090 |
Why?
|
| Interferon-gamma | 4 | 2013 | 576 | 0.090 |
Why?
|
| Saliva | 2 | 2024 | 100 | 0.090 |
Why?
|
| Immunotherapy | 1 | 2014 | 274 | 0.090 |
Why?
|
| T-Lymphocytes | 2 | 2013 | 1012 | 0.090 |
Why?
|
| Female | 7 | 2024 | 34423 | 0.080 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2011 | 30 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 279 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2012 | 248 | 0.080 |
Why?
|
| Peptide Mapping | 1 | 2007 | 29 | 0.060 |
Why?
|
| Data Collection | 2 | 2022 | 384 | 0.060 |
Why?
|
| Cell Line | 2 | 2012 | 2031 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2004 | 97 | 0.060 |
Why?
|
| Adult | 3 | 2024 | 17575 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 449 | 0.060 |
Why?
|
| Alleles | 1 | 2007 | 455 | 0.060 |
Why?
|
| United States | 3 | 2024 | 8189 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2014 | 2651 | 0.060 |
Why?
|
| Point-of-Care Testing | 1 | 2024 | 41 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1291 | 0.050 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2004 | 27 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2024 | 117 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1590 | 0.050 |
Why?
|
| HLA-A2 Antigen | 1 | 2004 | 62 | 0.050 |
Why?
|
| Nose | 1 | 2024 | 27 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2004 | 194 | 0.050 |
Why?
|
| Neoplasms | 1 | 2014 | 1377 | 0.050 |
Why?
|
| Virus Shedding | 1 | 2022 | 17 | 0.050 |
Why?
|
| Georgia | 1 | 2022 | 92 | 0.050 |
Why?
|
| Young Adult | 2 | 2024 | 4882 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 18498 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2023 | 514 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 417 | 0.040 |
Why?
|
| Vero Cells | 1 | 2021 | 81 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2022 | 104 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 211 | 0.040 |
Why?
|
| Candidiasis, Invasive | 1 | 2020 | 9 | 0.040 |
Why?
|
| Candida | 1 | 2020 | 37 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 110 | 0.040 |
Why?
|
| Time Factors | 1 | 2007 | 3777 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2020 | 125 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 207 | 0.040 |
Why?
|
| Cognition | 1 | 2023 | 514 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2004 | 2089 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 692 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2020 | 437 | 0.030 |
Why?
|
| HIV-1 | 1 | 2001 | 710 | 0.030 |
Why?
|
| Critical Care | 1 | 2020 | 416 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 700 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 197 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 382 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2015 | 57 | 0.030 |
Why?
|
| Dependovirus | 1 | 2022 | 760 | 0.030 |
Why?
|
| Male | 3 | 2024 | 31406 | 0.030 |
Why?
|
| Virus Activation | 1 | 2014 | 23 | 0.030 |
Why?
|
| Virus Latency | 1 | 2014 | 31 | 0.030 |
Why?
|
| HIV Infections | 1 | 2001 | 961 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2017 | 326 | 0.030 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2014 | 13 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 267 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 995 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 199 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2022 | 852 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2015 | 189 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2015 | 256 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 2013 | 35 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 178 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 6367 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 233 | 0.020 |
Why?
|
| Survivors | 1 | 2014 | 187 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2013 | 129 | 0.020 |
Why?
|
| Genomics | 1 | 2015 | 387 | 0.020 |
Why?
|
| HLA-DR1 Antigen | 1 | 2012 | 28 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2012 | 140 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 15146 | 0.020 |
Why?
|
| Haplotypes | 1 | 2012 | 137 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 869 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2012 | 147 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2013 | 329 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2012 | 169 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2012 | 181 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 518 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 302 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 430 | 0.020 |
Why?
|
| Animals | 2 | 2021 | 21493 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 316 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1635 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1980 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 965 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 2675 | 0.020 |
Why?
|
| HIV Antigens | 1 | 2001 | 18 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 2001 | 96 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2001 | 67 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2001 | 180 | 0.010 |
Why?
|
| Virus Replication | 1 | 2001 | 323 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 758 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 11185 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 755 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 2194 | 0.010 |
Why?
|